Sequenom Revenues Rise 7 Percent as Net Loss More Than Doubles | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market on Wednesday that its first-quarter revenues rose 7 percent and its net loss more than doubled for the three months ended March 31.

The San Diego-based firm reported revenues of $10.6 million compared to $9.9 million in the first quarter of 2007. It said that the revenue increase was due primarily to an increase in sales of systems outside the US, consumable products sales, and growth in its contract research services group.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.